Assembly Biosciences (ASMB) EBITDA Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Assembly Biosciences (ASMB) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -1,651.00 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 29,091.00 |
| 10 | Assembly Biosciences | 683.92 Mn | 363.56 Mn | - | 6,780.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,780.00 |
| Mar 31, 2026 | -3,290.00 |
| Dec 31, 2025 | 20,337.00 |
| Sep 30, 2025 | 5,919.00 |
| Jun 30, 2025 | 2,777.00 |
| Mar 31, 2025 | 7,992.00 |
| Dec 31, 2024 | 1,847.00 |
| Sep 30, 2021 | -29,019.00 |
| Dec 31, 2020 | -322,104.00 |
| Sep 30, 2020 | 60,273.00 |
| Jun 30, 2020 | 65,632.00 |
| Mar 31, 2020 | 5,076.00 |
| Dec 31, 2019 | 10,302.00 |
| Sep 30, 2019 | -8,763.00 |
| Jun 30, 2019 | 20,458.00 |
| Mar 31, 2019 | -26,171.00 |
| Dec 31, 2018 | -33,431.00 |
| Sep 30, 2018 | -5,866.00 |
| Jun 30, 2018 | -26,906.00 |
| Mar 31, 2018 | 156,887.00 |